Pair Name | Capsaicin, Sorafenib | ||
Phytochemical Name | Capsaicin (PubChem CID: 1548943 ) | ||
Anticancer drug Name | Sorafenib (PubChem CID: 216239 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Capsaicin, Sorafenib | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Biological Phenomena | Induction-->Autophagy | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Expression | CASP3 | hsa836 | |
Down-regulation | Expression | EGFR | hsa1956 | |
Up-regulation | Expression | PARP1 | hsa142 | |
In Vitro Model | LM3 | Malignant neoplasms of the mouse mammary gland | Mus musculus (Mouse) | CVCL_D269 |
Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens (Human) | CVCL_0326 | |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens (Human) | CVCL_0336 | |
In Vivo Model | Five-week-old BALB/C nude mice received a subcutaneous injection of 1×10⁷ LM3 cells suspended in 100 uL sterile PBS into the right flank. | |||
Result | These data confirm that capsaicin and sorafenib combination treatment inhibits the growth, invasion and metastasis of HCC cells and induces autophagy in a synergistic manner, supporting its potential as a therapeutic option for HCC. |
No. | Title | Href |
---|---|---|
1 | Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling. Oncol Rep. 2018 Dec;40(6):3235-3248. doi: 10.3892/or.2018.6754. | Click |